Senator Investment Group LP Takes Position in MKS Inc. $MKSI

Senator Investment Group LP acquired a new position in shares of MKS Inc. (NASDAQ:MKSI) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 65,000 shares of the scientific and technical instruments company’s stock, valued at approximately $28,912,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in MKS by 3.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after buying an additional 9,170 shares during the period. EverSource Wealth Advisors LLC raised its position in MKS by 63.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock worth $83,000 after buying an additional 325 shares during the last quarter. First Trust Advisors LP raised its holdings in MKS by 3,545.6% during the second quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock worth $14,036,000 after purchasing an additional 137,392 shares in the last quarter. Cerity Partners LLC purchased a new position in shares of MKS during the 2nd quarter worth approximately $1,676,000. Finally, AXA S.A. lifted its holdings in MKS by 22.8% in the second quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock valued at $2,907,000 after acquiring an additional 5,430 shares during the period. Institutional investors and hedge funds own 99.79% of the company’s stock.

MKS Stock Performance

NASDAQ:MKSI opened at $255.76 on Monday. The company has a market capitalization of $17.29 billion, a PE ratio of 40.79, a price-to-earnings-growth ratio of 0.54 and a beta of 1.98. The company has a quick ratio of 0.72, a current ratio of 1.14 and a debt-to-equity ratio of 0.85. MKS Inc. has a 52-week low of $97.50 and a 52-week high of $447.62. The stock has a fifty day simple moving average of $330.20 and a 200-day simple moving average of $295.86.

MKS (NASDAQ:MKSI) last released its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 EPS for the quarter, topping the consensus estimate of $2.91 by $0.39. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.20 billion. MKS had a net margin of 10.15% and a return on equity of 24.72%. The business’s revenue for the quarter was up 28.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.77 EPS. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. On average, equities research analysts expect that MKS Inc. will post 13.07 earnings per share for the current fiscal year.

MKS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Tuesday, August 25th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Tuesday, August 25th. MKS’s dividend payout ratio is 15.95%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on MKSI shares. KeyCorp upped their price target on shares of MKS from $360.00 to $475.00 and gave the stock an “overweight” rating in a research note on Monday, June 29th. Needham & Company LLC boosted their price objective on shares of MKS from $360.00 to $390.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. TD Cowen restated a “buy” rating on shares of MKS in a research report on Thursday, May 7th. BMO Capital Markets began coverage on shares of MKS in a report on Tuesday, June 30th. They issued an “outperform” rating and a $453.00 target price for the company. Finally, JPMorgan Chase & Co. lifted their price target on shares of MKS from $365.00 to $380.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, MKS currently has an average rating of “Moderate Buy” and an average price target of $382.86.

Insider Activity

In related news, CEO John Tseng-Chung Lee sold 10,000 shares of MKS stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $302.01, for a total transaction of $3,020,100.00. Following the completion of the transaction, the chief executive officer directly owned 134,776 shares in the company, valued at $40,703,699.76. The trade was a 6.91% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Michelle M. Mccarthy sold 2,434 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $315.23, for a total value of $767,269.82. Following the completion of the sale, the chief accounting officer directly owned 2 shares in the company, valued at approximately $630.46. The trade was a 99.92% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,891 shares of company stock worth $3,919,127 over the last ninety days. 0.57% of the stock is currently owned by insiders.

Key Headlines Impacting MKS

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Analysts raised multiple earnings estimates. Zacks increased its Q3 2026 EPS forecast to $3.60 from $3.22 and its FY2026 estimate to $12.76 from $11.86. Estimates were also raised for FY2027 to $16.52 from $15.00 and FY2028 to $20.10 from $18.24. Several quarterly forecasts through 2028 were increased as well, signaling stronger expected earnings momentum. Earnings Estimates Moving Higher for MKS
• Positive Sentiment: Wall Street price targets imply substantial potential upside. The average analyst target cited by Zacks indicates 49.8% potential appreciation, although the article cautions that price targets are not always reliable. The favorable earnings-revision trend could support the stock if it translates into stronger results. Wall Street Analysts Think MKS Could Surge
• Neutral Sentiment: Mizuho lowered its MKS price target to $330. The target reduction is a negative signal, but the revised target remains well above the level at which the stock recently traded. Mizuho Lowers MKS Price Target
• Negative Sentiment: The CEO sold company shares. CEO John Tseng-Chung Lee reportedly sold 10,000 shares for approximately $3 million. Insider selling can raise concerns about management’s view of near-term valuation or performance, even though it does not necessarily indicate a change in business fundamentals. MKS CEO Sells Shares

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.